Human cytomegalovirus (HCMV) encodes a protein related to the large (R1) subunit of ribonucleotide reductase (RR), but does not encode the corresponding small (R2) subunit. The R1 homologue, UL45, lacks many catalytic residues, and its impact on deoxyribonucleotide (dNTP) production remains unknown. Here, UL45 is shown to accumulate at late stages of infection and to be a virion tegument protein. To study UL45 function in its genome context, UL45 was disrupted by transposon insertion. The UL45-knockout (UL45-KO) mutant exhibited a growth defect in fibroblasts at a low m.o.i. and also a cell-to-cell spread defect. This did not result from a reduced dNTP supply because dNTP pools were unchanged in resting cells infected with the mutant virus. Irrespective of UL45 expression, all cellular RR subunits – S-phase RR subunits, and the p53-dependent p53R2 – were induced by infection. p53R2 was targeted to the infected cell nucleus, suggesting that HCMV diverts a mechanism normally activated by DNA damage response. Cells infected with the UL45-KO mutant were moderately sensitized to Fas-induced apoptosis relative to those infected with the parental virus. Together with the report on the UL45-KO endotheliotropic HCMV mutant (Hahn et al., J Virol76, 9551–9555, 2002), these data suggest that UL45 does not share the prominent antiapototic role attributed to the mouse cytomegalovirus homologue M45 (Brune et al., Science291, 303–305, 2001).
AurelianL.1998; Herpes simplex virus type 2: unique biological properties include neoplastic potential mediated by the PK domain of the large subunit of ribonucleotide reductase. Front Biosci 3:D237–249
BironK. K.,
FyfeJ. A.,
StanatS. C.,
LeslieL. K.,
SorrellJ. B.,
LambeC. U.,
CoenD. M.1986; A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc Natl Acad Sci U S A 83:8769–8773
BorstE. M.,
HahnG.,
KoszinowskiU. H.,
MesserleM.1999; Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli : a new approach for construction of HCMV mutants. J Virol 73:8320–8329
ChabesA.,
ThelanderL.2000; Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks. J Biol Chem 275:17747–17753
CheeM. S.,
BankierA. T.,
BeckS.12 other authors1990; Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154:125–169
ChungT. D.,
WymerJ. P.,
SmithC. C.,
KulkaM.,
AurelianL.1989; Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J Virol 63:3389–3398
ConnerJ.1999; The unique N terminus of herpes simplex virus type 1 ribonucleotide reductase large subunit is phosphorylated by casein kinase 2, which may have a homologue in Escherichia coli
. J Gen Virol 80:1471–1476
CooperJ.,
ConnerJ.,
ClementsJ. B.1995; Characterization of the novel protein kinase activity present in the R1 subunit of herpes simplex virus ribonucleotide reductase. J Virol 69:4979–4985
DeptoA. S.,
StenbergR. M.1992; Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis -acting elements and viral trans -acting proteins necessary for promoter activation. J Virol 66:3241–3246
FortunatoE. A.,
McElroyA. K.,
SanchezI.,
SpectorD. H.2000; Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 8:111–119
GallinaA.,
SimonciniL.,
GarbelliS.7 other authors1999; Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein. J Virol 73:1468–1478
GavrieliY.,
ShermanY.,
Ben-SassonS. A.1992; Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501
GernaG.,
PercivalleE.,
BaldantiF.,
SozzaniS.,
LanzariniP.,
GeniniE.,
LilleriD.,
RevelloM. G.2000; Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 74:5629–5638
GoldmacherV. S.,
BartleL. M.,
SkaletskayaA.10 other authors1999; A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A 96:12536–12541
GuittetO.,
HakanssonP.,
VoevodskayaN.,
FriddS.,
GraslundA.,
ArakawaH.,
NakamuraY.,
ThelanderL.2001; Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J Biol Chem 276:40647–40651
HahnG.,
JoresR.,
MocarskiE. S.1998; Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 95:3937–3942
HahnG.,
KhanH.,
BaldantiF.,
KoszinowskiU. H.,
RevelloM. G.,
GernaG.2002; The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J Virol 76:9551–9555
HeinemanT. C.,
CohenJ. I.1994; Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro
. J Virol 68:3317–3323
HobomU.,
BruneW.,
MesserleM.,
HahnG.,
KoszinowskiU. H.2000; Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol 74:7720–7729
IdowuA. D.,
Fraser-SmithE. B.,
PoffenbergerK. L.,
HermanR. C.1992; Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo
. Antiviral Res 17:145–156
JacobsonJ. G.,
LeibD. A.,
GoldsteinD. J.,
BogardC. L.,
SchafferP. A.,
WellerS. K.,
CoenD. M.1989; A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology 173:276–283
JohnsonR. A.,
HuongS. M.,
HuangE. S.2000; Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J Virol 74:1158–1167
KauppiB.,
NielsenB. B.,
RamaswamyS.,
LarsenI. K.,
ThelanderM.,
ThelanderL.,
EklundH.1996; The three-dimensional structure of mammalian ribonucleotide reductase protein R2 reveals a more-accessible iron-radical site than Escherichia coli R2. J Mol Biol 262:706–720
LangelierY.,
ChampouxL.,
HamelM.,
GuilbaultC.,
LamarcheN.,
GaudreauP.,
MassieB.1998; The R1 subunit of herpes simplex virus ribonucleotide reductase is a good substrate for host cell protein kinases but is not itself a protein kinase. J Biol Chem 273:1435–1443
LangelierY.,
BergeronS.,
ChabaudS.,
LippensJ.,
GuilbaultC.,
SassevilleA. M.,
DenisS.,
MosserD. D.,
MassieB.2002; The R1 subunit of herpes simplex virus ribonucleotide reductase protects cells against apoptosis at, or upstream of, caspase-8 activation. J Gen Virol 83:2779–2789
LemboD.,
GribaudoG.,
HoferA.7 other authors2000; Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. J Virol 74:11557–11565
LycksellP. O.,
IngemarsonR.,
DavisR.,
GraslundA.,
ThelanderL.1994; 1H NMR studies of mouse ribonucleotide reductase: the R2 protein carboxyl-terminal tail, essential for subunit interaction, is highly flexible but becomes rigid in the presence of protein R1. Biochemistry 33:2838–2842
MaciejewskiJ. P.,
BrueningE. E.,
DonahueR. E.,
MocarskiE. S.,
YoungN. S.,
St JeorS. C.1992; Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80:170–178
MocarskiE. S.Jr1996; Cytomegaloviruses and their replication. In Fields Virology , 3rd edn. vol 2 pp 2447–2492 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott–Raven;
ParadisH.,
GaudreauP.,
MassieB.,
LamarcheN.,
GuilbaultC.,
GravelS.,
LangelierY.1991; Affinity purification of active subunit 1 of herpes simplex virus type 1 ribonucleotide reductase exhibiting a protein kinase activity. J Biol Chem 266:9647–9651
PariG. S.,
AndersD. G.1993; Eleven loci encoding trans -acting factors are required for transient complementation of human cytomegalovirus ori-Lyt-dependent DNA replication. J Virol 67:6979–6988
PariG. S.,
KacicaM. A.,
AndersD. G.1993; Open reading frames UL44, IRS1/TRS1, and UL36–38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J Virol 67:2575–2582
PavloffN.,
RivardD.,
MassonS.,
ShenS. H.,
Mes-MassonA. M.1992; Sequence analysis of the large and small subunits of human ribonucleotide reductase. DNA Seq 2:227–234
RipaltiA.,
BoccuniM. C.,
CampaniniF.,
LandiniM. P.1995; Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol 69:2047–2057
RodemsS. M.,
SpectorD. H.1998; Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol 72:9173–9180
SanchezV.,
SztulE.,
BrittW. J.2000a; Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment. J Virol 74:3842–3851
SanchezV.,
GreisK. D.,
SztulE.,
BrittW. J.2000b; Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J Virol 74:975–986
SchmolkeS.,
KernH. F.,
DrescherP.,
JahnG.,
PlachterB.1995; The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol 69:5959–5968
SinzgerC.,
GrefteA.,
PlachterB.,
GouwA. S. H.,
TheT. H.,
JahnG.1995; Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76:741–750
SkaletskayaA.,
BartleL. M.,
ChittendenT.,
McCormickA. L.,
MocarskiE. S.,
GoldmacherV. S.2001; A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A 98:7829–7834
SmithC. C.,
AurelianL.1997; The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity. Virology 234:235–242
SmithC. C.,
PengT.,
KulkaM.,
AurelianL.1998; The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth. J Virol 72:9131–9141
SmithC. C.,
NelsonJ.,
AurelianL.,
GoberM.,
GoswamiB. B.2000; Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth. J Virol 74:10417–10429
Soderberg-NauclerC.,
FishK. N.,
NelsonJ. A.1997; Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119–126
SomiaN. V.,
SchmittMiyoshi M. J. H.,
VermaI. M.2000; Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping. J Virol 74:4420–4424
SongY. J.,
StinskiM. F.2002; Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis. Proc Natl Acad Sci U S A 99:2836–2841
TanakaH.,
ArakawaH.,
YamaguchiT.,
ShiraishiK.,
FukudaS.,
MatsuiK.,
TakeiY.,
NakamuraY.2000; A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42–49
YamaguchiT.,
MatsudaK.,
SagiyaY.,
IwadateM.,
FujinoM. A.,
NakamuraY.,
ArakawaH.2001; p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint. Cancer Res 61:8256–8262
YuY.,
AlwineJ. C.2002; Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3′-OH kinase pathway and the cellular kinase Akt. J Virol 76:3731–3738